Tested Applications
Positive FC detected in | MG-63 cells, Transfected HEK-293T cells |
Recommended dilution
Application | Dilution |
---|---|
Flow Cytometry (FC) | FC : 0.25 ug per 10^6 cells in 100 μl suspension |
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
98405-2-RR targets PDGFR beta/CD140b in FC applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Immunogen | PDGFR beta/CD140b fusion protein Eg3715 Predict reactive species |
Full Name | platelet-derived growth factor receptor, beta polypeptide |
Calculated Molecular Weight | 1106 aa, 124 kDa |
GenBank Accession Number | BC032224 |
Gene Symbol | PDGFR beta |
Gene ID (NCBI) | 5159 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
UNIPROT ID | P09619 |
Storage Buffer | PBS with 0.09% sodium azide, pH 7.3. |
Storage Conditions | Store at 2 - 8°C. Stable for one year after shipment. |
Background Information
PDGFRs are receptor tyrosine kinases with an extracellular ligand-binding domain and a cytoplasmic enzymatic domain. The signaling activity of PDGFRs is tightly regulated by an autoinhibitory allosteric conformation, and requires ligand-induced receptor dimerization at the cell surface to alleviate autoinhibition and achieve physiological activity (PMID: 21664579). PDGFR beta (platelet-derived growth factor receptor- β)/CD140b is a constitutive marker expressed by ASCs in the angiogenic behavior of human retinal endothelial cells (HREs). CD140b (PDGFRβ) plays a crucial role in controlling the intrinsic proliferation (PMID: 30976657)
Protocols
Product Specific Protocols | |
---|---|
FC protocol for PDGFR beta/CD140b antibody 98405-2-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |